Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 64, Issue 5, Pages 1653-1664
Publisher
Wiley
Online
2011-11-16
DOI
10.1002/art.33482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelin 1 contributes to the effect of transforming growth factor β1 on wound repair and skin fibrosis
- (2010) David Lagares et al. ARTHRITIS AND RHEUMATISM
- Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model
- (2010) Cedo M Bagi et al. CANCER BIOLOGY & THERAPY
- Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts
- (2010) Guo-qiang Cai et al. EXPERIMENTAL CELL RESEARCH
- Expression of integrin 1 by fibroblasts is required for tissue repair in vivo
- (2010) S. Liu et al. JOURNAL OF CELL SCIENCE
- Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
- (2010) M. D. Schaller JOURNAL OF CELL SCIENCE
- FRNK overexpression limits the depth and frequency of vascular smooth muscle cell invasion in a three-dimensional fibrin matrix
- (2010) L.P. Brewster et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Focal adhesion kinase mediates TGF-β1-induced renal tubular epithelial-to-mesenchymal transition in vitro
- (2010) Bingqing Deng et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Loss of β1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model
- (2009) Shangxi Liu et al. ARTHRITIS AND RHEUMATISM
- CTGF enhances migration and MMP-13 up-regulation via αvβ3 integrin, FAK, ERK, and NF-κB-dependent pathway in human chondrosarcoma cells
- (2009) Tzu-Wei Tan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Mechanically Activated Integrin Switch Controls 5 1 Function
- (2009) J. C. Friedland et al. SCIENCE
- Insulin-Like Growth Factor-II Is Increased in Systemic Sclerosis-Associated Pulmonary Fibrosis and Contributes to the Fibrotic Process via Jun N-Terminal Kinase- and Phosphatidylinositol-3 Kinase-Dependent Pathways
- (2008) Eileen Hsu et al. AMERICAN JOURNAL OF PATHOLOGY
- c-Jun N-Terminal Kinase 1 Is Required for the Development of Pulmonary Fibrosis
- (2008) John F. Alcorn et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Standardized quantification of pulmonary fibrosis in histological samples
- (2008) Ralf-Harto Hübner et al. BIOTECHNIQUES
- Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors
- (2008) Cedo M. Bagi et al. CANCER
- Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
- (2008) W. G. Roberts et al. CANCER RESEARCH
- Endothelin-1 promotes migration of endothelial cells through the activation of ARF6 and the regulation of FAK activity
- (2008) Zeinab Daher et al. CELLULAR SIGNALLING
- Protein Kinase Inhibitors in the Treatment of Pulmonary Fibrosis
- (2008) Sylvie Garneau-Tsodikova et al. CURRENT MEDICINAL CHEMISTRY
- Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner
- (2008) Qiang Ding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast adhesion results in the induction of a matrix remodeling gene expression program
- (2008) L KENNEDY et al. MATRIX BIOLOGY
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
- (2007) Antje Moeller et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started